1,042 results on '"Guerrini, Remo"'
Search Results
2. Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin
3. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
4. Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli
5. Fluorescent opioid receptor ligands as tools to study opioid receptor function
6. The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues
7. NOP-Targeted Peptide Ligands
8. Nociceptin/Orphanin FQ and Urinary Bladder
9. Cu(II) coordination to His-containing linear peptides and related branched ones: Equalities and diversities
10. (L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky ‘Forced-Traceless’ Regioselective Pd-Catalyzed C(sp2)–H Activation
11. (L)-Mono-methyl Tyrosine (Mmt): new synthetic strategy via bulky ‘forced-traceless’ regioselective Pd-catalyzed C(sp2)–H activation
12. Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5
13. NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine
14. In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells
15. Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease
16. Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: a pivotal role in stress-induced analgesia
17. (L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp 2)–H Activation.
18. Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin.
19. AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions
20. Central noradrenergic activity affects analgesic effect of Neuropeptide S
21. CCR4 + CD8 + T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis
22. Central noradrenergic activity affects analgesic effect of Neuropeptide S
23. NOP-Targeted Peptide Ligands
24. Nociceptin/Orphanin FQ and Urinary Bladder
25. Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5
26. Central adenosine A1 and A2A receptors mediate the antinociceptive effects of neuropeptide S in the mouse formalin test
27. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
28. In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells
29. Author response: Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
30. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P
31. A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ
32. Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors
33. Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer.
34. CCR4+CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis.
35. Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness
36. Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
37. Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption
38. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)
39. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth.
40. Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task
41. Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line
42. Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase
43. Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands
44. Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon
45. Serum beta‐secretase 1 (BACE1) activity increases in patients with mild cognitive impairment
46. Fluorescent opioid receptor ligands as tools to study opioid receptor function
47. Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
48. Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity
49. Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice
50. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.